Table 5.
Common Terminology Criteria for Adverse Events (CTCAE) reporting genitourinary toxicity scores at time-points after salvage high-dose- rate brachytherapy (sHDR-BT)
| Parameter | 1 month post-sHDR-BT | 3 months post-sHDR-BT | |
|---|---|---|---|
| Bladder perforation, n (%) | |||
| 0 | 16 (94) | 17 (100) | |
| 1 | 1 (6) | 0 (0) | |
| Bladder spasm, n (%) | |||
| 0 | 5 (29) | 6 (35) | |
| 1 | 2 (12) | 1 (6) | |
| 2 | 10 (59) | 10 (59) | |
| Cystitis, n (%) | |||
| 0 | 10 (59) | 12 (71) | |
| 1 | 7 (41) | 5 (29) | |
| Dysuria, n (%) | |||
| 0 | 13 (76) | 15 (88) | |
| 1 | 4 (24) | 1 (6) | |
| 2 | 0 (0) | 1 (6) | |
| Urinary frequency, n (%) | |||
| 0 | 5 (29) | 5 (29) | |
| 1 | 12 (71) | 7 (41) | |
| 2 | 0 (0) | 5 (29) | |
| Urinary incontinence, n (%) | |||
| 0 | 12 (71) | 9 (53) | |
| 1 | 3 (18) | 7 (41) | |
| 2 | 2 (12) | 1 (6) | |
| Urinary retention, n (%) | |||
| 0 | 14 (82) | 13 (77) | |
| 1 | 3 (18) | 3 (18) | |
| 2 | 0 (0) | 1 (6) | |
| Urinary obstruction, n (%) | |||
| 0 | 9 (53) | 8 (47) | |
| 1 | 7 (41) | 9 (53) | |
| 2 | 1 (6) | 0 (0) | |
| Urinary pain, n (%) | |||
| 0 | 14 (82) | 12 (71) | |
| 1 | 3 (18) | 4 (24) | |
| 2 | 0 (0) | 1 (6) | |
| Urinary urgency, n (%) | |||
| 0 | 4 (24) | 6 (35) | |
| 1 | 9 (53) | 8 (47) | |
| 2 | 4 (24) | 3 (18) | |
| Prostatic pain, n (%) | |||
| 0 | 16 (94) | 15 (88) | |
| 1 | 1 (6) | 1 (6) | |
| 2 | 0 (0) | 1 (6) | |